Oral Answers to Questions

Rishi Sunak Excerpts

Wednesday 5th November 2025 Commons Chamber

[The Deputy Prime Minister]

I am deeply saddened by the loss of life and the scenes of devastation in the great country of Jamaica. Like my hon. Friend, I have relatives in Jamaica, and I thank and commend her for her personal fundraising efforts. The Prime Minister and the Foreign Secretary have been in touch with their counterparts to offer our full support, with £7.5 million of aid funding already mobilised. We have chartered flights from Jamaica for British nationals who are unable to fly home commercially. Jamaica will also receive $71 million from the Caribbean Catastrophe Risk Insurance Facility pool—funding that began under the previous Labour Government and that Jamaica can draw on for its renewal.

[Rishi Sunak (Richmond and Northallerton) (Con)]

I thank the Deputy Prime Minister for joining me at a recent event in Parliament to support the work of Prostate Cancer Research, a charity of which I am an ambassador. He and I both believe that introducing a targeted national screening programme for prostate cancer is the right thing to do and would save lives. Does he agree that the recent compelling results of the 162,000-patient European trial support the case, and that that evidence, alongside data from Prostate Cancer Research and others, should be given significant weight by the UK National Screening Committee?

[The Deputy Prime Minister]

I thank the right hon. Member for raising the issue. Sadly, too many of us will know someone affected by prostate cancer; too many members of my family are currently living with prostate cancer. I was proud to co-chair the Prostate Cancer Research event last year and this year with him, and I share his determination to boost research, speed up treatment and deliver better care. He knows that I am biased, but these are rightly decisions for the Secretary of State for Health and Social Care. The UK National Screening Committee is reviewing the latest evidence for prostate screening and considering whether any changes should be made to save lives, and we have invested £42 million jointly with Prostate Cancer UK—